A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2002
12/25/2002	CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/24/2002	US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002	US6498178 Inhibitors of IMPDH enzyme
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002	US6498164 Such as 1,3-dibenzyl-5-(phenyl- or 2-thienyl-acetyl)barbi-turic acid; malignant hypercalcemia, osteolytic diseases such as paget's disease, osteoporosis, articular rheumatism occurring in knees, shoulders, joints
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002100901A2 Determination of bone-sialoprotein in bodily fluids for oncological problems
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100888A1 Somatostatin-dopamine chimeric analogs
12/19/2002	WO2002100880A1 Method for preparing oestrogen derivatives
12/19/2002	WO2002100859A1 Pde iv inhibitors
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100486A1 Method and apparatus for treating uterine myoma
12/19/2002	WO2002100445A1 Treatment and composition for wound healing
12/19/2002	WO2002100426A1 Bmp binding proteins for use in bone or cartilage regeneration
12/19/2002	WO2002100422A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/19/2002	WO2002100419A1 Use of a phosphate adsorbent to combat vascular diseases
12/19/2002	WO2002100412A2 Stabilized dispersion of phytosterol in oil
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002100332A2 Isoxazoline compounds having mif antagonist activity
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002092606A8 Fused imidazolidine derivatives, process for preparation of the same and use thereof
12/19/2002	WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002	WO2002078684A3 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002	WO2002066624A3 Novel human protease and polynucleotides encoding the same
12/19/2002	WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002	WO2002058681A3 Use of rhein for preparing a medicine for treating a high level of il-1
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	WO2002042248A3 Naphthalene derivatives
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2002005836A3 Stimulation of bone growth with thrombin peptide derivatives
12/19/2002	WO2001047919A9 Substituted oxazolidinones and their use in the field of blood coagulation
12/19/2002	US20020193627 Prepared by neutralizing pamidronic acid with sodium compound, drying disodium pamidronate, dissolving in water, filtering sparingly soluble materials, allowing the filtrate to crystallize
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193446 Compounds and methods for the inhibition of the expression of VCAM-1
12/19/2002	US20020193421 Substituted bonzoic acid derivatives, useful for preventing and/or treating tumors, arthritis, and non-malignant skin disorders
12/19/2002	US20020193414 Adamantane derivatives
12/19/2002	US20020193410 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
12/19/2002	US20020193409 Prodrugs of anticancer agents employing substituted aromatic acids
12/19/2002	US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002	US20020193377 Quinazolines as MMP-13 inhibitors
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192305 Inflammatory mediation obtained from atractylodes lancea
12/19/2002	US20020192280 Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192157 Treatment and diagnosis of macrophage mediated disease
12/19/2002	DE10128511A1 Treating or preventing atherosclerosis and/or bone metabolism disorders, especially in dialysis patients, using polynuclear metal oxide-modified adsorption material
12/19/2002	DE10127897A1 Combined pharmaceutical formulation for treating osteoporosis or related disorders, comprising core of dried plant extract enclosed in sheath of calcium salt
12/19/2002	CA2852202A1 Calcium phosphate delivery vehicles for osteoinductive proteins
12/19/2002	CA2450240A1 Treatment and composition for wound healing
12/19/2002	CA2450027A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449934A1 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	CA2449573A1 Bmp binding proteins for use in bone or cartilage regeneration
12/19/2002	CA2449247A1 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/19/2002	CA2446223A1 Stabilized dispersion of phytosterol in oil
12/18/2002	EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002	EP1266899A2 Rapamycin hdroxyesters, process for their preparation and pharmaceutical compositions containing them
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002	EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002	EP1265986A2 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265916A2 Therapeutic anti-cytomegalovirus compounds
12/18/2002	EP1265905A1 Il-8 receptor antagonists
12/18/2002	EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002	EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002	EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002	EP1265878A1 A process for the preparation of epothiline analogs and intermediates
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265864A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
12/18/2002	EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors

1 ... 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 ... 820